In order to reduce angiogenetic progression in breast cancer, Egorova et al. [70] used an L1 peptide-based polyplex for the delivery of siRNAs targeting VEGFA, VEGFR1, and endoglin transcripts in CXCR4-positive breast cancer and endothelial cells lines. The gene discussed is FLT1; the disease is breast cancer.